A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis
CompletedOBSERVATIONAL
Enrollment
30
Participants
Timeline
Start Date
October 31, 2005
Primary Completion Date
October 31, 2009
Study Completion Date
December 31, 2009
Conditions
Relapsing Remitting Multiple Sclerosis
All Listed Sponsors
lead
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY
NCT00203086 - A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis | Biotech Hunter | Biotech Hunter